/Investor DB

Stoic VC

Venture capital

Sydney · Seed–Series A · 5 people tracked

Find your way into Stoic VC

Sign up to see every warm intro you have to Stoic VC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Stoic VC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Stoic backs scientists and engineers commercialising research from leading Australian universities, aiming to turn breakthrough science into commercially viable, high-velocity technologies. It focuses on three areas: human health (products advancing standard of care), advanced computing (next-generation processing and computational systems), and the physical world (addressing environmental challenges). The firm typically enters after a startup has demonstrated proof of concept of its research, writing first cheques from roughly A$100K to A$1M. Partnered with Uniseed since 2019, it offers founders direct access to investors, operators and academics, drawing on decades of commercialisation experience and connections across ten of Australia's top research institutions.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
Check
$65K – $650K
HQ
Sydney, AU
Leads rounds
Follows
Instruments
Equity
Founded
2019
Tracked investments
25

Team · 5 people

from the firm's website

What they invest in

from 17 of 25 portfolio companies

Healthtech ×11Medical Devices ×11Biotech ×8Digital Health ×5AI & Machine Learning ×3Hardware ×3IoT ×3Deep Tech ×2

HQs:Australia×11United States×2

Investments · 25 tracked

founders shown can be your intro path
Kinoxis Therapeuticskinoxistherapeutics.comin𝕏✓ verified

Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.

BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU

Hugh Alsop(Chief Executive Officer, Co-Founder)inMichael Bowen(Chief Scientific Officer, Co-Founder)in

Co-investorsUniSeed Pty Ltd.

Axelia Oncologyaxeliaoncology.com

Axelia Oncology is a biopharmaceutical company developing AXA-042, a selective immunological agent designed to activate innate immune responses against checkpoint-insensitive solid tumors.

BiotechHealthtechMedical DevicesMelbourne, AU

David Jackson(Founder (Laboratory research origin))Grant Mchlachlan(Chief Executive Officer)

Co-investorsUniSeed Pty Ltd.

BioScout Automated Agricultural Disease Detectionbioscout.com.auin𝕏

BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing.

AgTechAI & Machine LearningDeep TechHardwareIoT

Lewis Collins(CEO)in

Co-investorsArtesianUniSeed Pty Ltd.

Cardihab Improving cardiovascular diseasecardihab.comin𝕏

Cardihab provides a digital cardiac rehabilitation platform that uses smartphone apps and web portals to enable clinicians to deliver remote and flexible rehabilitation services to patients with heart disease.

Digital HealthHealthtechMedical DevicesQueensland, AU

Co-investorsUniSeed Pty Ltd.

CERTA Therapeuticscertatherapeutics.comin

Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis.

BiotechHealthtechMedical Devices

Co-investorsUniSeed Pty Ltd.

Ena Respiratoryenarespiratory.comin

ENA Respiratory develops and brings respiratory treatments to market across the US and other regions.

BiotechHealthtechMedical DevicesMelbourne, AU

Christophe Demaison(CEO)in

Co-investorsBrandon BioCatalystUniSeed Pty Ltd.

Exonate - companyexonate.comin𝕏

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.

BiotechDigital HealthHealthtechMedical Devices

Olav Hellebø(Chief Executive Officer)in

Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupEMV CapitalMartlet Capital+1 more

Ferronovaferronova.com.auin

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.

BiotechHealthtechMedical Devices

Benjamin Thierry(Scientific Advisor/Founder)inStewart Bartlett(CEO)inAnil Shetty(CMO)in

Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundMatūUniSeed Pty Ltd.

Lenexa Medicallenexamedical.comin

Lenexa Medical provides fabric-based sensor technology and AI software embedded in hospital mattresses to continuously monitor patient positioning and pressure, enabling healthcare staff to prevent pressure injuries through real-time data and targeted interventions.

AI & Machine LearningDigital HealthHealthtechMedical DevicesMelbourne, AU

Ajit Ravindran(CEO)inWill Yang(CSO)in

Co-investorsMedTech Actuator

Morse Micromorsemicro.comin𝕏

Morse Micro designs Wi-Fi HaLow (IEEE 802.11ah) system-on-chip semiconductors that provide long-range, low-power sub-1 GHz wireless connectivity for IoT devices such as security cameras, dongles, and access points.

HardwareIoTSemiconductorsSydney, AU

Andrew Terry(Founder)inMichael De Nil(Founder)inJoe Bedewi(Chief Financial Officer)in

Co-investorsMain Sequence VenturesBlackbird VenturesRight Click CapitalSpringCapital InvestmentUniSeed Pty Ltd.Virescent Ventures+2 more

NatureHelmnaturehelm.comin𝕏

NatureHelm is a biodiversity intelligence platform that aggregates remote sensing and ground-based species data to help corporations, financial institutions, and primary producers assess and report nature-related risks, impacts, and dependencies.

Climate TechData & InfrastructureSaaS

Dr Debbie Saunders(Co-founder, Conservation Ecologist & CEO)inPhil Keaton(Co-founder, Innovative Technology & CPO)inAlexandra Kmita(CMO)

Co-investorsUniSeed Pty Ltd.

NEURODEneurodelabs.com𝕏

Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.

AI & Machine LearningDigital HealthHardwareMedical DevicesMental Health

Damian(CTO)

Co-investorsPsyMed Ventures

OccuRxoccurx.com

An online gambling platform licensed under Curacao eGaming, offering video slots, live dealer tables, progressive jackpots, and specialty games from studios such as NetEnt, Microgaming, and Pragmatic Play.

Co-investorsBrandon BioCatalystBrandon Capital Partners

PERKiiperkii.comin

PERKii is a beverage company that produces probiotic drinks designed to support gut health and immunity.

ConsumerFoodTechHealthtechWellness & FitnessBrisbane, AU

Co-investorsBrisbane Angels

Q Seraq-sera.com

Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.

BiotechHealthtechMedical DevicesBrisbane, AU

Michael Grant(Chief Executive Officer)in

Co-investorsBrandon BioCatalystUniSeed Pty Ltd.

QUEoncology Healthier menopause treatmentsqueoncology.com

QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy.

BiotechFemTechHealthtechMedical DevicesAtlanta, US

Co-investorsBrandon BioCatalyst

Sese.app𝕏

EcoStruxure is Schneider Electric's IoT-enabled, open and interoperable platform and architecture for homes, buildings, data centers, infrastructure, and industry, spanning connected products, edge control, and apps, analytics, and services.

CleantechEnergyIoT

UniSeed Pty Ltd.uniseed.comin𝕏

Uniseed is a commercialisation fund that provides seed capital, mentoring and network access to researchers from its partner research organisations, helping them turn technology innovations into products and businesses.

Deep TechSector Agnostic

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BioScoutCardihabForciteKinoxisLenexaNexgenplantsQUE Oncology

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Stoic VC made?
Stoic VC has 25 tracked investments.
What stage does Stoic VC invest at?
Stoic VC invests at the Seed, Series A stages.
What is Stoic VC's typical check size?
Stoic VC typically writes checks of $65K – $650K.
What sectors does Stoic VC focus on?
Stoic VC focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Healthtech, Medical Devices.
Where is Stoic VC located?
Stoic VC is headquartered in Sydney, AU.
Does Stoic VC lead rounds?
Stoic VC typically participates in rounds rather than leading them.
Who does Stoic VC co-invest with?
Stoic VC most often shares deals with UniSeed Pty Ltd., Brandon BioCatalyst, Artesian, among 17 tracked co-investors.

Similar investors

Featured in lists